Direkt zum Inhalt
Merck
  • Epigenetic profiling reveals a developmental decrease in promoter accessibility during cortical maturation in vivo.

Epigenetic profiling reveals a developmental decrease in promoter accessibility during cortical maturation in vivo.

Neuroepigenetics (2016-12-19)
Ishwariya Venkatesh, Matthew T Simpson, Denise M Coley, Murray G Blackmore
ZUSAMMENFASSUNG

Axon regeneration in adult central nervous system (CNS) is limited in part by a developmental decline in the ability of injured neurons to re-express needed regeneration associated genes (RAGs). Adult CNS neurons may lack appropriate pro-regenerative transcription factors, or may display chromatin structure that restricts transcriptional access to RAGs. Here we performed epigenetic profiling around the promoter regions of key RAGs, and found progressive restriction across a time course of cortical maturation. These data identify a potential intrinsic constraint to axon growth in adult CNS neurons. Neurite outgrowth from cultured postnatal cortical neurons, however, proved insensitive to treatments that improve axon growth in other cell types, including combinatorial overexpression of AP1 factors, overexpression of histone acetyltransferases, and pharmacological inhibitors of histone deacetylases. This insensitivity could be due to intermediate chromatin closure at the time of culture, and highlights important differences in cell culture models used to test potential pro-regenerative interventions.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Roche
cOmplete, EDTA-freier Proteasehemmer-Cocktail, Tablets provided in EASYpacks
Sigma-Aldrich
Anti-β-Tubulin-III in Kaninchen hergestellte Antikörper, affinity isolated antibody, buffered aqueous solution
Sigma-Aldrich
Anacardinsäure
Sigma-Aldrich
CPTH2, ≥98% (HPLC), powder